HYPERGLYCEMIA

This study tests whether a daily tablet of semaglutide (Rybelsus) can safely control high blood sugar in people who recently had a kidney transplant. About 104 participants will receive either the drug or a placebo for 14 weeks, alongside standard care. The goal is to see if the …

This study tests whether taking a daily zinc supplement for 12 months can lower blood sugar and HbA1c levels in people with prediabetes. Researchers will compare zinc to a placebo in 200 Amish adults aged 18-80 who have prediabetes. The goal is to see if zinc can help control blo…

This study looks at whether eating all your food within a specific 9-hour window each day (time-restricted eating) can improve blood sugar control in people with obesity who have or are at risk for type 2 diabetes. Researchers will compare three different eating windows to see if…

This study is testing a smartphone mini-program that gives personalized exercise plans to people with high blood pressure, high blood sugar, high cholesterol, and high uric acid (the 'Four Highs'). Researchers want to see if using the app for six months helps people become more a…

This study looks at whether closely monitoring and controlling blood sugar levels can help people with pancreatic cancer who are receiving chemotherapy. About 50 participants will wear a continuous glucose monitor and be randomly assigned to either tight blood sugar control or st…

This study tests whether breathing a special mix of low and high oxygen air (called IHHT) for 3 or 10 days can help control blood sugar in people with type 2 diabetes, including older adults. About 250 participants aged 50-74 will be randomly assigned to short or long treatment o…

This study tests whether a wearable breath sensor can detect high or low blood sugar (hyperglycemia or hypoglycemia) in teens with type 1 diabetes. Participants wear the device for 72 hours and provide breath samples while their blood sugar is measured. The goal is to find a noni…

This study is testing whether using a continuous glucose monitor (CGM) helps people with diabetes feel more in control of their blood sugar after they leave the hospital. About 60 adults with type 1 or type 2 diabetes will use a CGM for a short time and answer questionnaires abou…

This study tests a non-invasive device that gently stimulates a nerve in the ear to see if it can lower inflammation and pain after major spine surgery. Researchers will measure inflammatory markers and pain scores in 50 adults undergoing long-segment spinal fusion. The goal is t…

This early-stage study tests a new capsule called TQF3250 in 66 healthy adults to see if it is safe and how the body handles it. The drug is designed to help control high blood sugar by targeting a specific receptor, potentially with fewer side effects than current treatments. Pa…

This study aims to confirm whether high sugar levels in the fluid around the brain and in the blood soon after a brain aneurysm rupture are linked to needing a permanent shunt. Researchers will measure sugar levels daily in 160 adults who have a temporary drain placed. Participan…

This study looks at whether a continuous glucose monitor (CGM) — a small sensor worn under the skin — can help screen women for diabetes risk after having gestational diabetes. About 20 women will wear the CGM for a short time after giving birth and answer surveys about their exp…

This study looks at whether a special computer program can help doctors better manage blood sugar levels in hospitalized adults. The tool alerts care teams when a patient's blood sugar is too high or too low, so they can act quickly. Researchers will track how long patients stay …

This study tests a new smartphone app and continuous glucose monitor in 30 young adults aged 16-24 who were diagnosed with type 2 diabetes before age 18. Participants wear a glucose monitor and Fitbit for 30 days, answer surveys, and give feedback on health messages. The goal is …

This study looks at whether the standard A1C blood sugar test is accurate for people with type 2 diabetes who have a Left Ventricular Assist Device (LVAD). Researchers will compare A1C results with data from a continuous glucose monitor (CGM) worn for 3 months. The goal is to see…